Drug intelligence / Profile preview

allogeneic adipose-derived mesenchymal stem cells (Medical University of Warsaw)

Development stage
Unknown
Lead developer
Medical University of Warsaw
Modality
Stem Cell Therapies → Cell Therapies
Administration
Topical
01

Overview

Allogenic ADSC cells (also known as CSCC_ASC) is an investigational advanced therapy medicinal product (ATMP) consisting of live allogeneic mesenchymal stem cells isolated from adipose tissue, delivered in a fibrin carrier. Developed by the Medical University of Warsaw in collaboration with the Medical Research Agency of Poland, it is primarily being studied for the treatment of chronic diabetic foot ulcers (diabetic foot syndrome). The therapy works through paracrine and regenerative mechanisms, promoting wound healing and tissue repair by modulating the wound microenvironment and stimulating angiogenesis. In Phase 2 clinical trials (FOOTCELL), the product demonstrated efficacy in reducing wound size and increasing complete healing rates compared to fibrin gel alone.

Other names
Allogenic ADSC cellsallogenic adipose-derived mesenchymal stem cellsallogenic ASCsallogeneic adipose-derived stem cells

Beyond the preview

Go deeper on allogeneic adipose-derived mesenchymal stem cells (Medical University of Warsaw).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on allogeneic adipose-derived mesenchymal stem cells (Medical University of Warsaw).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call